Warfarin therapy not warranted for secondary prevention of CVD

Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

Long Wong, Dan Criswell

Research output: Contribution to journalShort surveyResearchpeer-review

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalEvidence-Based Practice
Volume12
Issue number12
StatePublished - 1 Dec 2009

Fingerprint

Warfarin
Secondary Prevention
Aspirin
Stroke
Therapeutics

Cite this

@article{8153bb4674e445608fa8d1bc62e26a58,
title = "Warfarin therapy not warranted for secondary prevention of CVD: Warfarin is no better than aspirin for preventing recurrent ischemic strokes.",
author = "Long Wong and Dan Criswell",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "12",
pages = "1--2",
journal = "Evidence-Based Practice",
issn = "1095-4120",
publisher = "Dowden Health Media,Inc",
number = "12",

}

Warfarin therapy not warranted for secondary prevention of CVD : Warfarin is no better than aspirin for preventing recurrent ischemic strokes. / Wong, Long; Criswell, Dan.

In: Evidence-Based Practice, Vol. 12, No. 12, 01.12.2009, p. 1-2.

Research output: Contribution to journalShort surveyResearchpeer-review

TY - JOUR

T1 - Warfarin therapy not warranted for secondary prevention of CVD

T2 - Warfarin is no better than aspirin for preventing recurrent ischemic strokes.

AU - Wong, Long

AU - Criswell, Dan

PY - 2009/12/1

Y1 - 2009/12/1

UR - http://www.scopus.com/inward/record.url?scp=77951887074&partnerID=8YFLogxK

M3 - Short survey

VL - 12

SP - 1

EP - 2

JO - Evidence-Based Practice

JF - Evidence-Based Practice

SN - 1095-4120

IS - 12

ER -